They have confirmed that the risk for LPD is increased in pSS patients with parotidomegaly, lymphadenomegaly, and antibody positivity to Sjögren's syndrome-specific nuclear and cytosolic antigens (anti-SS-A/-SS-B) [13]. This evidence concerns the gene SSB and disseminated peritoneal leiomyomatosis.